A consultancy in NHS primary care market access, founded and led by a GPhC-registered pharmacist with operational experience across EMIS, SystmOne, Drug Tariff, dm+d and GP engagement. Parent company of Vima Access.
Vima Clinical was founded in 2021 by Vivek Patel, a GPhC-registered pharmacist with a track record of running national market access programmes inside one of the UK's most active primary care consultancies.
Vivek Patel brings hands-on, real-world experience across the full UK primary care market access stack: clinical system listings on EMIS and SystmOne, Drug Tariff and dm+d submissions, wholesaler catalogue audits, NHSBSA prescribing analytics, and direct GP engagement.
Most recently as Operations Director and Head of Market Access at Oberoi Consulting, Vivek led national programmes for pharmaceutical, medtech and digital health clients launching into NHS primary care. That operational grounding (knowing where products actually get stuck on the way from MHRA approval to a GP prescribing decision) is the foundation Vima Clinical is built on.
Vima Clinical exists to channel that experience into two things: a software product, Vima Access, that makes the journey legible for every drug in a pharma client's portfolio; and selected consulting engagements where a deeper advisory relationship matters more than a self-serve tool.
Market access in UK primary care comes down to a sequence of operational steps that get missed when launch planning focuses on KOLs and messaging. Vima Clinical makes those steps explicit, sequenced, and accountable, for every drug in a pharma client's portfolio and every ICB in England.
A market access intelligence platform purpose-built for UK pharma. The journey from MHRA approval to first prescription, mapped end-to-end across every drug in your portfolio and every ICB in England.
How each product in your portfolio is listed, reimbursed and prescribed across the NHS. Verified by the Vima Clinical team and kept current.
Visit vima-access.com ↗Vima Clinical takes a small number of advisory engagements each year. These are bespoke pieces of work where deep, hands-on involvement from the founder is the right fit, not a productised service catalogue.
For pharma teams preparing a launch and asking the right questions early: dm+d submission timing, AMPP / pack-level considerations, clinical system listing pathways for EMIS and SystmOne, wholesaler engagement, and the operational checklist that gets missed when the launch plan focuses on KOLs and messaging.
For products already in market where prescribing isn't moving: a structured diagnostic across the same operational layers (catalogue listing, formulary positioning, Drug Tariff state, ICB-level access friction) with concrete recommendations and optional implementation support.
If your situation doesn't match either of these and you think we'd add value, get in touch anyway. A short conversation usually surfaces whether there's something useful to do.
Get in touchFor consulting enquiries, partnerships, press, or general questions about the company. Product demos and platform support for Vima Access route through vima-access.com.